U.S. markets closed

Adaptive Biotechnologies Corporation (ADPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
3.9900-0.0400 (-0.99%)
At close: 04:00PM EST
3.9700 -0.02 (-0.50%)
After hours: 08:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 3/5/2024
Market Cap (intraday)
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (5 yr expected)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Trading Information

Stock Price History

Beta (5Y Monthly) 1.27
52-Week Change 3-53.14%
S&P500 52-Week Change 328.87%
52 Week High 39.0800
52 Week Low 32.6050
50-Day Moving Average 34.2386
200-Day Moving Average 35.5336

Share Statistics

Avg Vol (3 month) 31.44M
Avg Vol (10 day) 31.21M
Shares Outstanding 5144.77M
Implied Shares Outstanding 6145.13M
Float 898.5M
% Held by Insiders 11.78%
% Held by Institutions 197.51%
Shares Short (Feb 15, 2024) 49.19M
Short Ratio (Feb 15, 2024) 46.23
Short % of Float (Feb 15, 2024) 48.15%
Short % of Shares Outstanding (Feb 15, 2024) 46.35%
Shares Short (prior month Jan 12, 2024) 48.76M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023


Profit Margin -132.28%
Operating Margin (ttm)-99.68%

Management Effectiveness

Return on Assets (ttm)-16.60%
Return on Equity (ttm)-58.34%

Income Statement

Revenue (ttm)170.28M
Revenue Per Share (ttm)1.18
Quarterly Revenue Growth (yoy)-17.10%
Gross Profit (ttm)N/A
EBITDA -179.38M
Net Income Avi to Common (ttm)-225.25M
Diluted EPS (ttm)-1.5600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)346.4M
Total Cash Per Share (mrq)2.39
Total Debt (mrq)229.43M
Total Debt/Equity (mrq)74.42%
Current Ratio (mrq)4.66
Book Value Per Share (mrq)2.13

Cash Flow Statement

Operating Cash Flow (ttm)-156.32M
Levered Free Cash Flow (ttm)-81.95M